OneMedNet (ONMD) Chief Medical Officer Yu Buys $100K of Stock
OneMedNet's Chief Medical Officer, Jeffrey Yu, purchased 158,730 shares at $0.63 each.
Reviewed by automated data checks against the source filing. How we make and check alerts
Jeffrey Yu, Chief Medical Officer at OneMedNet Corporation ($ONMD), bought 158,730 shares at an average price of $0.63, worth about $99,999.90, on June 23, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $ONMD is up 18.5% after 1 week, up 0.3% after 1 month and down 24.8% to date (from the $6 close on Jun 23, 2026).
ONMD
OneMedNet Corporation
Key Points
- Jeffrey Yu, Chief Medical Officer of OneMedNet Corporation, bought 158,730 shares on June 23, 2026, at $0.63 per share, totaling nearly $100,000.
- Shares of ONMD traded at $0.64 on Wednesday, with a market cap of approximately $30.4 million and a 52-week range of $0.34 to $4.22.
- Other institutions like Exencial Wealth Advisors and Vanguard Capital Management also adjusted their positions in OneMedNet.
Get $ONMD trade alerts by text
We text you when insiders, Congress or big funds trade $ONMD. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated OneMedNet Corporation alert may contain errors. Disclosures
On June 23, 2026, Jeffrey Yu, the Chief Medical Officer of OneMedNet Corporation, made a notable purchase of 158,730 shares at a price of $0.63 each. This transaction was not part of a pre-arranged trading plan and was valued at nearly $100,000.
Insider Buying and Selling at OneMedNet Corporation
Jeffrey Yu wasn't the only insider active in June. On the same day he made his purchase, Aaron Green, the CEO, also acquired 36,650 shares at $0.57 each. Earlier that month, Yu added another 172,414 shares to his holdings on June 16, at a price of $0.58 per share. These transactions indicate a pattern of accumulation by the company's top executives.
Other Institutional Activity in OneMedNet Corporation
Institutional investors have also been adjusting their stakes in OneMedNet. Exencial Wealth Advisors increased its holdings by 4,732,698 shares, resulting in a total of 8,377,559 shares valued at approximately $7.12 million, reflecting a 129.8% increase. Vanguard Capital Management opened a new position with 1,115,565 shares worth about $948,230. Geode Capital Management added 41,802 shares, bringing its total to 338,528 shares valued at $287,782, marking a 14.1% increase. Additionally, Vanguard Fiduciary Trust Co and Citigroup Inc both initiated new positions, each acquiring over 135,000 shares.
OneMedNet Corporation Stock Down 87.3%
As of Wednesday, shares of OneMedNet Corporation (NasdaqCM: ONMD) traded at $0.64. The company has a market cap of roughly $30.4 million and a beta of 1.122, indicating moderate volatility. Over the past year, the stock has seen a low of $0.34 and a high of $4.22. The 50-day moving average is $0.85, while the 200-day moving average stands at $1.15. However, with a current ratio of 0.273 and a quick ratio of 0.174, the company's liquidity appears tight.
Recent Earnings
OneMedNet reported revenue of $1.32 million, though it experienced a revenue decline of 29.9%. The company is not yet profitable, with a net margin of -254.325%. As a result, it has no meaningful P/E ratio. The company’s financials highlight ongoing challenges in achieving profitability.
About OneMedNet Corporation
OneMedNet Corporation is a healthcare software company based in Eden Prairie, Minnesota. It specializes in digital medical image management, exchange, and sharing solutions across the Americas, Europe, and the Middle East. Its products include iRWD, which provides regulatory-grade imaging and clinical data for the pharmaceutical and device manufacturing sectors, and BEAM, a platform for medical imaging exchange among healthcare systems and patients. Led by CEO Aaron Green, the company employs 22 people.
Bottom Line
Insider purchases by Jeffrey Yu and other executives suggest confidence in OneMedNet Corporation's future. The company's stock, while volatile, remains of interest to both insiders and institutional investors. However, the financials indicate challenges, as reflected in recent revenue declines and negative margins. Investors and analysts continue to watch for signs of a turnaround as the company navigates its financial landscape.
Related Filing Alerts
Source: Jeffrey Yu's Form 4 filing on $ONMD (Jun 23, 2026). Find the original filing: ONMD Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts